A multicenter randomized-controlled trial of nucleos(t)ide analogue cessation in HBeAg-negative chronic hepatitis B

• DOI: 10.1016/j.jhep.2022.12.018
• Publication Date: 2023-03-28T23:59:10Z
• Authors: Florian van Bömmel; Kerstin Stein; Renate Heyne; Jörg Petersen; Peter Buggisch; Christoph Berg; Stefan Zeuzem; Andreas Stallmach; Martin Sprinzl; Eckart Schott; Anita Pathil-Warth; Ulrike von Arnim; Verena Keitel; Jürgen Lohmeyer; Karl-Georg Simon; Christian Trautwein; Andreas Trein; Dietrich Hüppe; Markus Cornberg; Frank Lammert; Patrick Ingiliz; Reinhart Zachoval; Holger Hinrichsen; Alexander Zipprich; Hartmuth Klinker; Julian Schulze zu...; Anett Schmiedeknecht; Oana Brosteanu; Thomas Berg
• Keywords: Discontinuation; HBeAg; Clinical endpoint; Hepatitis B; Multicenter trial

Published by Elsevier Science, Amsterdam [u.a.]<br/>Journal of hepatology 78(5), 926-936 (2023). doi:10.1016/j.jhep.2022.12.018<br/>